Litsea salicifolia Roxb. bark ethanolic extract attenuates rheumatoid arthritis by inhibiting TLR4/NF-κB and activating SIRT1-Nrf2/HO-1 signaling axis: In-vitro and in-vivo evaluations-Reference-Cited by-同舟云学术

Litsea salicifolia Roxb. bark ethanolic extract attenuates rheumatoid arthritis by inhibiting TLR4/NF-κB and activating SIRT1-Nrf2/HO-1 signaling axis: In-vitro and in-vivo evaluations

Published:2023-02 Issue:1 Volume:3 Page:100390
ISSN:2667-0313
Container-title:Phytomedicine Plus
language:en
Short-container-title:Phytomedicine Plus

Author:

Puppala Eswara Rao,Abubakar Md.,Swamy Veerabhadra,Yalamarthi Sai Sudha,NP Syamprasad,Prakash Arun N.,Gangasani Jagadeesh Kumar,Chamundeswari D.,Naidu V.G.M.

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference36 articles.

1. Diagnosis and management of rheumatoid arthritis: a review;Aletaha;JAMA,2018

2. NF-κB, inflammation, and metabolic disease;Baker;Cell. Metab.,2011

3. Oxidative stress in inflammatory cells of patient with rheumatoid arthritis: clinical efficacy of dietary antioxidants;Bala;Inflammopharmacology,2017

4. A novel bioavailable curcumin-galactomannan complex modulates the genes responsible for the development of chronic diseases in mice: a RNA sequence analysis;Banik;Life Sci.,2021

5. Adverse events with disease modifying antirheumatic drugs (DMARD): a cohort study of leflunomide compared with other DMARD;Cannon;J. Rheumatol.,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tinospora cordifolia Miers enhances the immune response in mice immunized with JEV-vaccine: A network pharmacology and experimental approach;Phytomedicine;2023-10

2. Loganic acid protects against ulcerative colitis by inhibiting TLR4/NF-κB mediated inflammation and activating the SIRT1/Nrf2 anti-oxidant responses in-vitro and in-vivo;International Immunopharmacology;2023-09

3. Design of chondroitin sulphate coated proglycosomes for localized delivery of tofacitinib for the treatment of rheumatoid arthritis;European Journal of Pharmaceutics and Biopharmaceutics;2023-05